|
|
| Device |
over-the-counter covid-19 antigen test |
| Definition |
For the rapid, qualitative detection of SARS-CoV-2 virus nucleocapsid protein antigen in individuals 2 years and older. |
| Product Code | QYT |
| Regulation Number |
866.3984
|
| Device Class |
2
|
| Premarket Reviews |
| Manufacturer | Decision |
| ABBOTT DIAGNOSTICS SCARBOROUGH, INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| ACCESS BIO, INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| ACON LABORATORIES, INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
2
|
| ASSURE TECH., LLC |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| CORDX, INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| GENABIO DIAGNOSTICS, INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| GENBODY.INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| GUANGZHOU WONDFO BIOTECH CO., LTD. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| HEALGEN SCIENTIFIC,, LLC |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| IHEALTH LABS, INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| INBIOS INTERNATIONAL, INC. |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| OSANG, LLC |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
| QUIDEL CORPORATION |
| |
SUBSTANTIALLY EQUIVALENT
|
1
|
|
| MDR Year |
MDR Reports |
MDR Events |
| 2024 |
23 |
23 |
| 2025 |
83 |
83 |
| 2026 |
33 |
33 |
|
|
|
|